Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Fat cells help recruit healing cells and build skin structure during wound healing.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Platelet-rich plasma might help with hair growth and skin conditions, but more research is needed to prove its effectiveness and safety.

Mesenchymal stem cells are key to future tissue regeneration in oral surgery.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.